Warning: The NCBI web site requires JavaScript to function. more...
Department of Neurology, Hokkaido University Graduate School of Medicine, Sapporo. hirotani@med.hokudai.ac.jp
Interferon-alpha (IFN-alpha), though widely used for the treatment of chronic viral hepatitis, may be associated with the occurrence of autoimmune disorders. In this case report, a patient with chronic hepatitis C virus infection had chronic inflammatory demyelinating polyneuropathy (CIDP) after the initiation of IFN-alpha therapy. The neurological symptoms of this patient continued to progress even though the treatment with IFN-alpha had been withdrawn; the symptoms improved dramatically following treatment with intravenous immunoglobulin. This case may therefore provide an important clue to understand the immune mechanism of CIDP and IFN-alpha.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on